Causes and Risk Factors for Anal Cancer
Anal cancer, though relatively rare, is a serious condition, with new cases and deaths increasing in the United States. Understanding its primary causes and key risk factors is crucial for effective prevention and early detection strategies.
Key Takeaways
- According to the National Cancer Institute, HPV infection is the leading cause of anal cancer, linked to more than 90% of cases.
- Immunosuppression — including HIV, organ transplantation, and certain autoimmune conditions — significantly raises the risk of developing anal cancer.
- Lifestyle factors such as smoking, having multiple sexual partners, and receptive anal intercourse also raise risk, largely by increasing the chance of persistent HPV infection.
- Anal cancer typically develops gradually from precancerous changes known as anal intraepithelial neoplasia (AIN), or anal dysplasia.
- HPV vaccination, along with regular screening for higher-risk individuals, is an important tool for prevention and early detection.
Primary Causes of Anal Cancer
The primary causes of anal cancer are linked mainly to persistent viral infection and the cellular changes it can trigger. Not everyone exposed to these factors develops the disease, but understanding them is fundamental to understanding anal cancer causes and how the condition forms.
The Role of HPV Infection
The most significant factor in what causes anal cancer is persistent infection with high-risk types of human papillomavirus (HPV). HPV infection itself is extremely common: almost everyone who is sexually active acquires it at some point, often not long after becoming sexually active, and most infections clear on their own without treatment. The National Cancer Institute (NCI) reports that more than 90% of anal cancer cases are linked to HPV, most often high-risk types such as HPV-16 and HPV-18, which together drive the majority of HPV-related cancers overall. Persistent infection with these high-risk types interferes with how infected cells divide and grow, letting abnormal cells multiply unchecked; this process has been studied mostly in the cervix, but HPV-related cancers at other sites, including the anus, are thought to arise through similar mechanisms. Left untreated, these abnormal changes can eventually progress to cancer, though only a small share of people with high-risk HPV ever develop anal cancer, reflecting the role of other contributing factors.
Major Risk Factors for Anal Cancer
Beyond HPV infection itself, several other factors raise the likelihood of developing anal cancer, largely by increasing exposure to HPV or making it harder for the body to clear the infection. Identifying these risk factors for anal cancer is essential for understanding who is at risk for anal cancer and for targeted prevention.
Immunosuppression and HIV
People with weakened immune systems face a substantially higher risk of anal cancer. This includes people living with HIV, organ transplant recipients who take immunosuppressive medicine to prevent rejection, and people with autoimmune disorders such as Crohn disease or psoriasis — though it isn’t fully clear whether the added risk in autoimmune disease comes from the condition itself, its treatment, or a combination of both. Men who have sex with men and are living with HIV face a greater anal cancer risk than HIV-negative men in the same group, and HIV-positive women likewise face increased risk relative to HIV-negative women. Long-term immune suppression is thought to raise risk mainly by making it harder for the body to clear HPV, letting the infection linger and advance toward precancerous changes.
Lifestyle and Behavioral Risks
Certain lifestyle and behavioral factors also shape risk, generally by increasing exposure to HPV or making it harder for the body to fight off infection and abnormal cell growth.
- Smoking: Cigarette smoking is an established risk factor for anal cancer, and current smokers appear to have a higher risk than people who have quit or never smoked.
- Multiple sexual partners: Having more lifetime sexual partners increases the chance of exposure to HPV, raising the odds of a persistent high-risk infection.
- Receptive anal intercourse and sex between men: These increase the chance of HPV exposure in the anal area and are associated with a higher risk of anal cancer.
- History of other HPV-related cancer: A past diagnosis of cervical, vaginal, or vulvar cancer — cancers also tied to HPV — raises a woman’s likelihood of later developing anal cancer, pointing to a shared underlying cause.
How Anal Cancer Develops
Anal cancer typically develops gradually, moving from normal cells through precancerous changes and, in some cases, to invasive cancer — a process that generally unfolds over years.
Precancerous Lesions (AIN)
Abnormal cell changes in the anal canal caused by persistent high-risk HPV infection are known as anal dysplasia, or anal intraepithelial neoplasia (AIN). Dysplasia is graded from low-grade (mild) changes, which often resolve on their own as the infection clears, to moderate or high-grade changes that are considered precancerous and generally need treatment. AIN itself is not cancer, but high-grade AIN carries a greater chance of progressing to invasive disease if it isn’t found and treated.
Progression to Invasive Cancer
If high-grade AIN goes undetected and untreated, the abnormal cells can continue to grow and eventually invade tissue beyond the lining of the anal canal, marking the shift to invasive anal cancer. How long this takes varies from person to person, but it often takes years. Finding and treating AIN early helps prevent this progression, since invasive cancer is harder to treat and carries a greater risk of spreading to other parts of the body.
Reducing Your Anal Cancer Risk
No strategy eliminates all risk, but a few evidence-based steps can meaningfully lower the chance of developing anal cancer.
HPV Vaccination
Vaccination is one of the most effective ways to reduce the risk of HPV-related cancers, including anal cancer, since it protects against the high-risk HPV types responsible for most cases. The Centers for Disease Control and Prevention calls for routine HPV vaccination at age 11 or 12. Dosing can begin as early as age 9 and stays an option through age 26 for anyone not fully vaccinated when younger. Adults ages 27 through 45 who missed vaccination earlier may still choose it, though the CDC notes the added benefit is smaller at this age since most people have already encountered HPV by then — a decision best made together with a healthcare provider.
Screening and Early Detection
There is no standard anal cancer screening test recommended for the general public. For people at higher risk — such as those with HIV, a history of high-grade AIN, or the other risk factors described above — a healthcare provider may recommend periodic screening, such as an anal Pap test, to help find precancerous changes or early cancer before symptoms appear. Ask your provider whether screening makes sense for you and how often it should be repeated.
Frequently Asked Questions
Can anal cancer be cured?
Yes, anal cancer is often curable, especially when found early. Treatment typically combines radiation therapy and chemotherapy, known as chemoradiation; surgery is typically used only if the cancer persists or returns after this initial treatment. Regular follow-up afterward is important to watch for recurrence and manage any lasting side effects.
Is anal cancer contagious?
Anal cancer itself is not contagious. Its main cause, HPV infection, is a sexually transmitted infection spread through skin-to-skin contact, typically during sexual activity. HPV infection is common, and only a small share of people with high-risk HPV ever develop anal cancer, usually over many years. Safer sex practices and HPV vaccination can help reduce the risk of transmission.
Are there any early warning signs of anal cancer?
Early anal cancer often causes no noticeable symptoms, which is one reason screening matters for people at higher risk. Symptoms that do occur can resemble more common conditions like hemorrhoids, so any new or persistent change in the anal area is worth discussing with a doctor for proper evaluation.
Sources
